Trials / Completed
CompletedNCT01889537
Low Dose Ketamine VR Analgesia During Burn Care Procedure
Low Dose Ketamine to Enhance VR Analgesia During Painful Burn Care Procedure.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 3 (actual)
- Sponsor
- National Institute of General Medical Sciences (NIGMS) · NIH
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the research is to see whether a low dose of ketamine, a medication used to reduce pain, enhances the effectiveness of a virtual reality video game, which is used as a form of distraction from pain during a painful burn care procedure.
Detailed description
This study is conducted in a hospital setting. It is a randomized controlled trial comparing the use of virtual reality distraction (VRD) and standard pain medications to the use of VRD, standard pain medications and a single low dose of ketamine as a means to reduce pain during a painful procedure in patients in the hospital.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Virtual Reality | The patient will receive virtual reality during a burn care procedure |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2013-06-28
- Last updated
- 2017-09-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01889537. Inclusion in this directory is not an endorsement.